• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在稳定期精神分裂症患者中,较高程度的洞察力损害与静息状态下高频心率变异性所反映的心脏迷走神经张力降低有关。

A higher degree of insight impairment in stabilized schizophrenia patients is associated with reduced cardiac vagal tone as indexed by resting-state high-frequency heart rate variability.

作者信息

Ma Chin-Chao, Kao Yu-Chen, Tzeng Nian-Sheng, Chao Che-Yi, Chang Chuan-Chia, Chang Hsin-An

机构信息

Department of Psychiatry, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan; Department of Psychiatry, Tri-Service General Hospital Beitou Branch, National Defense Medical Center, Taipei, Taiwan.

Department of Psychiatry, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan; Department of Psychiatry, Tri-Service General Hospital Songshan Branch, National Defense Medical Center, Taipei, Taiwan.

出版信息

Asian J Psychiatr. 2020 Oct;53:102171. doi: 10.1016/j.ajp.2020.102171. Epub 2020 May 16.

DOI:10.1016/j.ajp.2020.102171
PMID:32454438
Abstract

Varying degrees of impaired clinical insight in schizophrenia differentially impact medication adherence and clinical outcomes, prompting in-depth investigations of the deficits. Research is scarce on the differences in peripheral physiological markers between varying degrees of impaired insight. The aims of this study were to examine the differences in (1) resting-state high-frequency heart rate variability (HF-HRV) and (2) crucial clinical outcomes between schizophrenia patients with varying degrees of insight impairment as measured by the Positive and Negative Syndrome Scale (PANSS) item G12 (lack of judgment and insight). The study recruited a sample of 95 stabilized schizophrenia patients with insight impairment. Patients were divided into 2 groups of either minimal insight impairment (n = 25, PANSS G12 = 2-3) or moderate-to-severe insight impairment (n = 70, PANSS G12 ≥ 4). Patients with moderate-to-severe insight impairment displayed lower HF-HRV, clinician-rated psychosocial function, medication adherence, and working memory capacity, and higher self-reported psychosocial function and life quality, but comparable cognitive insight compared to those with minimal insight impairment. A logistic regression model predicted moderate-to-severe insight impairment based on HF-HRV values at the optimal cut-off point of 3.655, with the sensitivity and specificity 84% and 72%, respectively. HF-HRV seems a peripheral marker sensitively reflecting central pathophysiology implicated in insight impairment of schizophrenia.

摘要

精神分裂症患者不同程度的临床洞察力受损对药物依从性和临床结局有不同影响,这促使人们对这些缺陷进行深入研究。关于不同程度洞察力受损患者外周生理指标差异的研究较少。本研究的目的是探讨:(1)静息状态下高频心率变异性(HF-HRV);(2)通过阳性和阴性症状量表(PANSS)项目G12(缺乏判断力和洞察力)测量的不同程度洞察力受损的精神分裂症患者之间关键临床结局的差异。该研究招募了95名病情稳定的有洞察力受损的精神分裂症患者样本。患者被分为两组,即轻度洞察力受损组(n = 25,PANSS G12 = 2-3)或中度至重度洞察力受损组(n = 70,PANSS G12≥4)。与轻度洞察力受损患者相比,中度至重度洞察力受损患者的HF-HRV、临床医生评定的社会心理功能、药物依从性和工作记忆能力较低,而自我报告的社会心理功能和生活质量较高,但认知洞察力相当。逻辑回归模型根据HF-HRV值在最佳临界点3.655预测中度至重度洞察力受损,敏感性和特异性分别为84%和72%。HF-HRV似乎是一个外周标志物,能敏感地反映精神分裂症洞察力受损所涉及的中枢病理生理学。

相似文献

1
A higher degree of insight impairment in stabilized schizophrenia patients is associated with reduced cardiac vagal tone as indexed by resting-state high-frequency heart rate variability.在稳定期精神分裂症患者中,较高程度的洞察力损害与静息状态下高频心率变异性所反映的心脏迷走神经张力降低有关。
Asian J Psychiatr. 2020 Oct;53:102171. doi: 10.1016/j.ajp.2020.102171. Epub 2020 May 16.
2
Insight and medication adherence in schizophrenia: An analysis of the CATIE trial.精神分裂症患者的洞察力与药物依从性:对CATIE试验的分析
Neuropharmacology. 2020 May 15;168:107634. doi: 10.1016/j.neuropharm.2019.05.011. Epub 2019 May 9.
3
Impaired insight in schizophrenia: impact on patient-reported and physician-reported outcome measures in a randomized controlled trial.精神分裂症患者的自知力受损:一项随机对照试验中患者报告结局和医生报告结局测量的影响。
BMC Psychiatry. 2022 Aug 28;22(1):574. doi: 10.1186/s12888-022-04190-w.
4
Insight and its relationship to clinical outcomes in patients with schizophrenia or schizoaffective disorder receiving long-acting risperidone.接受长效利培酮治疗的精神分裂症或分裂情感性障碍患者的洞察力及其与临床结局的关系。
Int Clin Psychopharmacol. 2006 Jul;21(4):233-40. doi: 10.1097/00004850-200607000-00006.
5
Insight Into Illness and Cognition in Schizophrenia in Earlier and Later Life.对精神分裂症患者早年及晚年疾病与认知的洞察。
J Clin Psychiatry. 2017 Apr;78(4):e390-e397. doi: 10.4088/JCP.16m10741.
6
Resting vagal activity in schizophrenia: meta-analysis of heart rate variability as a potential endophenotype.精神分裂症的静息迷走神经活动:心率变异性作为一种潜在的内表型的荟萃分析。
Br J Psychiatry. 2016 Jan;208(1):9-16. doi: 10.1192/bjp.bp.114.160762.
7
Combined effect of prefrontal transcranial direct current stimulation and a working memory task on heart rate variability.前额叶经颅直流电刺激与工作记忆任务对心率变异性的联合作用
PLoS One. 2017 Aug 3;12(8):e0181833. doi: 10.1371/journal.pone.0181833. eCollection 2017.
8
High vagally mediated resting-state heart rate variability is associated with superior working memory function.高迷走神经介导的静息态心率变异性与卓越的工作记忆功能相关。
Front Neurosci. 2023 Feb 20;17:1119405. doi: 10.3389/fnins.2023.1119405. eCollection 2023.
9
Heart rate variability as a potential indicator of positive valence system disturbance: A proof of concept investigation.心率变异性作为正性情绪系统紊乱的潜在指标:一项概念验证研究。
Int J Psychophysiol. 2015 Nov;98(2 Pt 2):240-248. doi: 10.1016/j.ijpsycho.2015.08.005. Epub 2015 Aug 14.
10
Insight across mental disorders: A multifaceted metacognitive phenomenon.洞察精神障碍:一种多方面的元认知现象。
Psychiatriki. 2019 Jan-Mar;30(1):13-16. doi: 10.22365/jpsych.2019.301.13.

引用本文的文献

1
The Effects of Bi-Anodal tDCS Over the Prefrontal Cortex Regions With Extracephalic Reference Placement on Insight Levels and Cardio-Respiratory and Autonomic Functions in Schizophrenia Patients and Exploratory Biomarker Analyses for Treatment Response.额极双相经颅直流电刺激联合颅外参考电极对精神分裂症患者洞察水平及心肺自主功能的影响及治疗反应的探索性生物标志物分析
Int J Neuropsychopharmacol. 2021 Jan 20;24(1):40-53. doi: 10.1093/ijnp/pyaa063.